Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-09-22 Purchase | 2020-09-23 09:20 am | Protara Therapeutics Inc. | TARA | Davis Blaine Chief Financial Officer | 1,481 | $16.91 | $25,038 | 1,481 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-01-02 Option Award | 2024-01-04 5:08 pm | N/A 2034-01-01 | Cartesian Therapeutics Inc. | RNAC | Davis Blaine Chief Financial Officer | 5,534,000 | $0 | 5,534,000 (Direct) | View |
2023-11-13 Disposition | 2023-11-15 5:26 pm | N/A 2032-11-27 | Cartesian Therapeutics Inc. | RNAC | Davis Blaine Chief Financial Officer | 1,250,000 | $0.79 | 0 (Direct) | View |
2022-11-28 Option Award | 2022-11-30 4:40 pm | N/A 2032-11-27 | SELECTA BIOSCIENCES INC | SELB | Davis Blaine Chief Financial Officer | 1,250,000 | $0 | 1,250,000 (Direct) | View |
2022-07-15 Tax Withholding | 2022-07-19 4:31 pm | N/A N/A | Protara Therapeutics Inc. | TARA | Davis Blaine Chief Financial Officer | 5,081 | $3.13 | 20,662 (Direct) | View |
2022-01-03 Option Award | 2022-01-05 4:35 pm | N/A 2032-01-02 | Protara Therapeutics Inc. | TARA | Davis Blaine Chief Financial Officer | 98,900 | $0 | 100,381 (Direct) | View |
2021-01-19 Option Award | 2021-01-21 3:05 pm | N/A 2031-01-18 | Protara Therapeutics Inc. | TARA | Davis Blaine Chief Financial Officer | 75,000 | $0 | 75,000 (Direct) | View |
2020-02-11 Option Award | 2020-02-11 7:51 pm | N/A 2030-02-10 | ArTara Therapeutics Inc. | TARA | Davis Blaine Chief Financial Officer | 94,000 | $0 | 94,000 (Direct) | View |